Literature DB >> 8544193

Fetal valproate syndrome.

J Clayton-Smith1, D Donnai.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8544193      PMCID： PMC1051674          DOI： 10.1136/jmg.32.9.724

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  21 in total

1.  Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.

Authors:  E Jäger-Roman; A Deichl; S Jakob; A M Hartmann; S Koch; D Rating; R Steldinger; H Nau; H Helge
Journal:  J Pediatr       Date:  1986-06       Impact factor: 4.406

2.  Maternal epilepsy, valproate exposure, and birth defects.

Authors:  P Mastroiacovo; R Bertollini; S Morandini; G Segni
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

3.  Valproate and birth defects.

Authors:  E Robert; F Rosa
Journal:  Lancet       Date:  1983-11-12       Impact factor: 79.321

4.  In-utero exposure to valproate and neural tube defects.

Authors:  D Lindhout; D Schmidt
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

5.  Congenital liver damage after treatment of mother with valproic acid and phenytoin?

Authors:  I Felding; A Rane
Journal:  Acta Paediatr Scand       Date:  1984-07

6.  Teratogenicity of valproic acid.

Authors:  B Dalens; E J Raynaud; J Gaulme
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

Review 7.  Congenital malformations associated with maternal use of valproic acid.

Authors:  C Huot; M Gauthier; M Lebel; A Larbrisseau
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

8.  The fetal valproate syndrome.

Authors:  J H DiLiberti; P A Farndon; N R Dennis; C J Curry
Journal:  Am J Med Genet       Date:  1984-11

9.  Fetal valproate syndrome: is there a recognisable phenotype?

Authors:  R M Winter; D Donnai; J Burn; S M Tucker
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

10.  Congenital anomalies in children of epileptic mothers and fathers.

Authors:  E Dieterich; A Steveling; A Lukas; N Seyfeddinipur; J Spranger
Journal:  Neuropediatrics       Date:  1980-08       Impact factor: 1.947
View more
  42 in total

1.  Drugs for epilepsy have teratogenic risks.

Authors:  E M Rosser; L C Wilson
Journal:  BMJ       Date:  1999-05-08

2.  Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism.

Authors:  Rachel Stadelmaier; Hanah Nasri; Curtis K Deutsch; Margaret Bauman; Anne Hunt; Christopher J Stodgell; Jane Adams; Lewis B Holmes
Journal:  Birth Defects Res       Date:  2017-06-21       Impact factor: 2.344

Review 3.  Dysmorphology demystified.

Authors:  William Reardon; Dian Donnai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

4.  Difficult airway in an infant with fetal valproate syndrome.

Authors:  Eiko Onishi; Hitoshi Ishii; Chikanobu Sasaki
Journal:  J Anesth       Date:  2013-12-01       Impact factor: 2.078

5.  Foetal surgery and using in utero therapies to reduce the degree of disability after birth. Could it be morally defensible or even morally required?

Authors:  Constantinos Kanaris
Journal:  Med Health Care Philos       Date:  2017-03

Review 6.  Cognitive/behavioral teratogenetic effects of antiepileptic drugs.

Authors:  Kimford J Meador; Gus Baker; Morris J Cohen; Eija Gaily; Michael Westerveld
Journal:  Epilepsy Behav       Date:  2007-11       Impact factor: 2.937

7.  Fetal valproate syndrome in a 2-month-old male infant.

Authors:  Syed A Zaki; Amol Phulsundar; Preeti Shanbag; Anupama Mauskar
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

Review 8.  Molecular and therapeutic potential and toxicity of valproic acid.

Authors:  Sébastien Chateauvieux; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  J Biomed Biotechnol       Date:  2010-07-29

9.  The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.

Authors:  Rebecca Louise Bromley; George E Mawer; Maria Briggs; Christopher Cheyne; Jill Clayton-Smith; Marta García-Fiñana; Rachel Kneen; Sam B Lucas; Rebekah Shallcross; Gus A Baker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-31       Impact factor: 10.154

10.  Baller-Gerold syndrome: Further evidence for association with prenatal exposure to valproate.

Authors:  Mary Lype; Py Henry; Cs Aravind; K Arun
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.